AbCellera Posts $10.6 Million in Q3 2026 Revenue, $0.13 Net Loss Per Share

AbCellera Biologics Inc. posted $10.6 million in revenue and a net loss of $0.13 per share for Q3 2026, the two headline figures in its latest quarterly results. The per-share loss was $0.13 on both a basic and diluted basis. AbCellera released its Q3 2026 results Nov. 9. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.